Review Article
The Protective Effects and Potential Mechanisms of Ligusticum chuanxiong: Focus on Anti-Inflammatory, Antioxidant, and Antiapoptotic Activities
Table 1
Protective effects of LC.
| Drug | Dose | Pathway | Model | Ref |
| Anti-inflammatory | | | | | Ligustrazine | 50, 100, 200 mg/kg | NLRP3/NF-κB↓ | CCl4-treated rats | [29] | Ligustilide | — | Protein kinase/NF-κB↓ | ApoE-/- mice | [15] | Ligustrazine | — | NF-κB↓ | Aβ25-35-treated microglial cells | [30] | Water extraction | — | TLR4/NF-κB↓ | MACO rat | [31] | Ligustrazine | 200 mg/kg | NF-κB↓, IL-10↓ | Spinal cord injury rats | [32] |
| Antioxidant | | | | | Polysaccharides | 2.95 mg/mL, 8 mg/mL | — | DPPH | [11] | Polysaccharides | 0.05–1.5 mg/mL | — | DPPH and H2O2 | [33] | Ethanol extraction | 600, 1200 mg/kg | Nrf2↑ | Isoproterenol-treated rats | [34] | Water extraction | 600, 1200 mg/kg | Nrf2↑ | Isoproterenol-treated rats | [34] | Ferulic acid | — | Keap/Nrf2/HO-1↑ | 2′,7′-Dichlorofluorescein diacetate-treated H9C2 cells | [35] | Polysaccharides | 10–50 mg/kg | PCG-1α/Nrf2↑ | Rat model | [28] |
| Antiapoptosis | | | | | Butanol part of ethanol extraction | 1–100 μM | PKA/CREB↑ | MTT-treated PC12 cells | [36] | Butanol part of ethanol extraction | 1–100 μM | Erk↑ | MTT-treated PC12 cells | [37] | Water extraction | — | TLR4↓ | MACO rats | [38] | Water extraction | — | Caspase-3↓ | MACO rats | [38] | Total phenolic acid | 0.2 mg/mL | Bax/Bcl-2↓ | MTT-treated human umbilical vein endothelial cells | [39] | Ethanol extraction | — | GAP-43↑ | Microsphere-induced cerebral embolism rats | [40] | Water extraction | — | CHP proteins↓ | MACO rats | [41] |
|
|